Supreme Petrochem manufactures styrenics products, including polystyrene, expandable polystyrene, and acrylonitrile butadiene styrene, serving domestic original equipment manufacturers and export markets. The company operates a 300,000 ton per annum polystyrene capacity, a 143,000 ton EPS capacity following a recent Phase 2 expansion, and a 70,000 ton ABS plant. The business sits as a converter, turning imported styrene monomer into specialized polymer compounds. Historically, blended EBITDA margins hovered between 6 and 9 percent, reflecting the commodity nature of base polystyrene and the inherent volatility of raw material pass-through. However, the company holds specialized polystyrene grades that command better pricing than standard industry products, and its EPS market position in North India demonstrates resilience against a highly fragmented local competitor base.
The durability of these economics relies heavily on customer qualification cycles and product specialization rather than scale alone. Original equipment manufacturer approvals for new ABS grades typically take 3 to 6 months, creating a switching cost barrier once a processor integrates the material. The company's mass ABS offers distinct physical advantages over imported emulsion-grade material, including a naturally white color that requires less pigment and provides cost advantages in masterbatch matching. Despite these advantages, the business remains fundamentally a converter game. India does not produce styrene monomer, meaning global prices dictate domestic realizations and the company must manage lean inventories of 30 to 40 days to mitigate raw material volatility. The competitive structure for mass ABS includes established imports from Korea and Taiwan, meaning the company must win market share through technical collaboration and localized supply reliability rather than pure cost leadership.
The next 18 to 24 months will be defined by the operationalization of new capacity and a shift in product mix toward higher value compounds. By June 2027, the company plans to commission a compounding capacity expansion to 80,000 tons per annum alongside a new 150,000 cubic meter wide-width EPS board line. A larger 80,000 ton polystyrene production line at the Amdoshi complex is slated for completion by December 2028, pushing total PS capacity to 380,000 tons. The immediate trigger is the restart of the 70,000 ton ABS plant, which suffered an equipment failure in December 2025. Management expects ABS capacity utilization to reach 80 to 85 percent of modified capacity this year, contributing to an 8 to 10 percent volume growth target for FY27. By late FY28, the business should look materially different, with a fully integrated ABS and compounding franchise reducing earnings volatility and new EPS grades positioned for European export markets under impending free trade agreements.
Management's execution record shows a mix of delivered promises and significant timeline slips. The company successfully commissioned the 70,000 ton ABS plant in September 2025 and completed the EPS Phase 2 expansion, bringing capacity to 143,000 tons. However, the ABS plant suffered a critical equipment malfunction in December 2025 and remains suspended, causing the company to miss its own volume targets for FY26 as 9M volumes remained flat year over year. The EPS Phase 2 expansion was also delayed from initial Q1 or Q2 FY26 guidance to early 2026. Despite these operational setbacks, the balance sheet remains pristine. The company is debt-free with an investible surplus of 463 crores as of December 2025, funding an estimated 900 crores of total announced capex entirely through internal accruals without dilution.
Earnings visibility hinges on the successful restart of the ABS plant and the stabilization of global styrene deltas. In Q1 FY27, total EBITDA margin surged to 20.3 percent driven by abnormally wide global deltas between styrene monomer and downstream products, with GPPS deltas peaking above 300. Management explicitly stated these margins will normalize as global deltas weaken to historical levels, meaning the current profit profile is structurally temporary. The kill shot for this thesis is a prolonged ABS plant shutdown or a renewed escalation in West Asia disrupting styrene supply. The company already established alternate raw material supply arrangements during a recent crisis, but this structurally increases freight costs and voyage times compared to the traditional 4 to 5 day Gulf supply route. If the ABS plant resumes operations and the 80,000 ton compounding expansion commissions by June 2027, the business will leverage operating leverage to absorb fixed costs and transition into a higher margin compounder.
companyname: Supreme Petrochem Limited ticker: SPLPETRO sector: Petrochemicals – Styrenics Supreme Petrochem Limited is an Indian petrochemical company incorporated in 1989. It manufactures and trades styrenic polymers, a family of plastics derived from styrene monomer (SM). The company is the largest domestic manufacturer of polystyrene (PS) and expandable polystyrene (EPS) in India, and also produces extruded polystyrene (XPS) insulation boards, ABS, and specialty polymer compounds. In FY2026...
Read the full report →capex, new product segment, geographic expansion
FY27 volume growth guided at 8-10% driven by ABS operationalization
Guidance upgradedmixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Supreme Petrochem Limited and 4,900+ companies.
5-day free pass. No card required.